• 1
    Trayhurn, P., and Beattie, J. H. (2001) Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc. Nutr. Soc. 60, 329339.
  • 2
    Rosen, E. D., and Spiegelman, B. M. (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847853.
  • 3
    Nedvidkova, J., Smitka, K., Kopsky, V., and Hainer, V. (2005) Adiponectin, an adipocyte-derived protein. Physiol Res 54, 133140.
  • 4
    Hotamisligil, G. S. (1999) The role of TNF alpha and TNF receptors in obesity and insulin resistance. J. Intern. Med. 245, 621625.
  • 5
    Rotter, V., Nagaev, I., and Smith, U. (2003) Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 278, 4577745784.
  • 6
    Bozaoglu, K., Bolton, K., McMillan, J., Zimmet, P., Jowett, J., et al. (2007) Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148, 46874694.
  • 7
    Nagpal, S., Patel, S., Jacobe, H., DiSepio, D., Ghosn, C., et al. (1997) Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J. Invest. Dermatol. 109, 9195.
  • 8
    Wittamer, V., Franssen, J. D., Vulcano, M., Mirjolet, J. F., Le Poul, E., et al. (2003) Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J. Exp. Med. 198, 977985.
  • 9
    Barnea, G., Strapps, W., Herrada, G., Berman, Y., Ong, J., et al. (2008) The genetic design of signaling cascades to record receptor activation. Proc. Natl. Acad. Sci. USA 105, 6469.
  • 10
    Zabel, B. A., Nakae, S., Zuniga, L., Kim, J. Y., Ohyama, T., et al. (2008) Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J. Exp. Med. 205, 22072220.
  • 11
    Goralski, K. B., McCarthy, T. C., Hanniman, E. A., Zabel, B. A., Butcher, E. C., et al. (2007) Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J. Biol. Chem. 282, 2817528188.
  • 12
    Muruganandan, S., Roman, A. A., and Sinal, C. J. (2010) Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J. Bone Miner. Res. 25, 222234.
  • 13
    Kaur, J., Adya, R., Tan, B. K., Chen, J., and Randeva, H. S. (2010) Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem. Biophys. Res. Commun. 391, 17621768.
  • 14
    Schultz, S., Saalbach, A., Heiker, J. T., Meier, R., Zellmann, T., et al. (2013) Proteolytic activation of prochemerin by kallikrein 7 breaks an ionic linkage and results in C-terminal rearrangement. Biochem. J. 452, 271280.
  • 15
    Parolini, S., Santoro, A., Marcenaro, E., Luini, W., Massardi, L., et al. (2007) The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109, 36253632.
  • 16
    Meder, W., Wendland, M., Busmann, A., Kutzleb, C., Spodsberg, N., et al. (2003) Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23. FEBS Lett. 555, 495499.
  • 17
    Du, X. Y., Zabel, B. A., Myles, T., Allen, S. J., Handel, T. M., et al. (2009) Regulation of chemerin bioactivity by plasma carboxypeptidase n, carboxypeptidase b (activated thrombin-activable fibrinolysis inhibitor), and platelets. J. Biol. Chem. 284, 751758.
  • 18
    Guillabert, A., Wittamer, V., Bondue, B., Godot, V., Imbault, V., et al. (2008) Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation. J. Leukoc. Biol. 84, 15301539.
  • 19
    Yamaguchi, Y., Du, X. Y., Zhao, L., Morser, J., and Leung, L. L. K. (2011) Proteolytic cleavage of chemerin protein is necessary for activation to the active form, Chem157S, which functions as a signaling molecule in glioblastoma. J. Biol. Chem. 286, 3951039519.
  • 20
    Zhao, L., Yamaguchi, Y., Sharif, S., Du, X. Y., Song, J. J., et al. (2011) Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma. J. Biol. Chem. 286, 3952039527.
  • 21
    Zabel, B. A., Allen, S. J., Kulig, P., Allen, J. A., Cichy, J., et al. (2005) Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J. Biol. Chem. 280, 3466134666.
  • 22
    Wittamer, V., Gregoire, F., Robberecht, P., Vassart, G., Communi, D., et al. (2004) The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J. Biol. Chem. 279, 99569962.
  • 23
    Gantz, I., Konda, Y., Yang, Y. K., Miller, D. E., Dierick, H. A., et al. (1996) Molecular cloning of a novel receptor (CMKLR1) with homology to the chemotactic factor receptors. Cytogenet. Cell Genet. 74, 286290.
  • 24
    Samson, M., Edinger, A. L., Stordeur, P., Rucker, J., Verhasselt, V., et al. (1998) ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur. J. Immunol. 28, 16891700.
  • 25
    Vermi, W., Riboldi, E., Wittamer, V., Gentili, F., Luini, W., et al. (2005) Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 201, 509515.
  • 26
    Dona, M., Fredman, G., Schwab, J. M., Chiang, N., Arita, M., et al. (2008) Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood 112, 848855.
  • 27
    Haack, K. K. V., and McCarty, N. A. (2011) Functional consequences of GPCR heterodimerization: GPCRs as allosteric modulators. Pharmaceuticals 4, 509523.
  • 28
    de Poorter, C., Baertsoen, K., Lannoy, V., Parmentier, M., and Springael, J. Y. (2013) Consequences of ChemR23 heteromerization with the chemokine receptors CXCR4 and CCR7. PLoS One 8, e58075.
  • 29
    Sohy, D., Yano, H., de Nadai, P., Urizar, E., Guillabert, A., et al. (2009) Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of “Selective” Antagonists. J. Biol. Chem. 284, 3127031279.
  • 30
    Joost, P., and Methner, A. (2002) Phylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands. Genome Biol. 3.
  • 31
    Rovati, G. E., Capra, V., and Neubig, R. R. (2007) The highly conserved DRY motif of class A G protein-coupled receptors: Beyond the ground state. Mol. Pharmacol. 71, 959964.
  • 32
    Marchese, A., Docherty, J. M., Nguyen, T., Heiber, M., Cheng, R., et al. (1994) Cloning of human genes encoding novel G-protein-coupled receptors. Genomics 23, 609618.
  • 33
    Shimizu, N., Soda, Y., Kanbe, K., Liu, H. Y., Jinno, A., et al. (1999) An orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of human immunodeficiency virus types 1 and 2 in brain-derived cells. J. Virol. 73, 52315239.
  • 34
    Edinger, A. L., Hoffman, T. L., Sharron, M., Lee, B., O'Dowd, B., et al. (1998) Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology 249, 367378.
  • 35
    Fan, P., Kyaw, H., Su, K., Zeng, Z. Z., Augustus, M., et al. (1998) Cloning and characterization of a novel human chemokine receptor. Biochem. Biophys. Res. Commun. 243, 264268.
  • 36
    Migeotte, I., Franssen, J. D., Goriely, S., Willems, F., and Parmentier, M. (2002) Distribution and regulation of expression of the putative human chemokine receptor HCR in leukocyte populations. Eur. J. Immunol. 32, 494501.
  • 37
    Monnier, J., Lewen, S., O'Hara, E., Huang, K., Tu, H., et al. (2012) Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells. J. Immunol. 189, 956967.
  • 38
    Damaj, B. B., McColl, S. R., Neote, K., Na, S. Q., Ogborn, K. T., et al. (1996) Identification of G-protein binding sites of the human interleukin-8 receptors by functional mapping of the intracellular loops. FASEB J. 10, 14261434.
  • 39
    Yoshimura, T., and Oppenheim, J. J. (2011) Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); Two multifunctional receptors with unusual properties. Exp. Cell Res. 317, 674684.
  • 40
    Becker, M., Rabe, K., Lebherz, C., Zugwurst, J., Goke, B., et al. (2010) Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. Diabetes 59, 28982903.
  • 41
    Landgraf, K., Friebe, D., Ullrich, T., Kratzsch, J., Dittrich, K., et al. (2012) Chemerin as a mediator between obesity and vascular inflammation in children. J. Clin. Endocrinol. Metab. 97, E556564.
  • 42
    Bozaoglu, K., Segal, D., Shields, K. A., Cummings, N., Curran, J. E., et al. (2009) Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. J. Clin. Endocrinol. Metab. 94, 30853088.
  • 43
    Chakaroun, R., Raschpichler, M., Kloting, N., Oberbach, A., Flehmig, G., et al. (2012) Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism 61, 706714.
  • 44
    Takahashi, M., Takahashi, Y., Takahashi, K., Zolotaryov, F. N., Hong, K. S., et al. (2008) Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett. 582, 573578.
  • 45
    Ernst, M. C., Haidl, I. D., Zuniga, L. A., Dranse, H. J., Rourke, J. L., et al. (2012) Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology 153, 672682.
  • 46
    Rouger, L., Denis, R., Luangsay, S., and Parmentier, M. (2013) ChemR23 knockout mice display mild obesity but no deficit in adipocyte differentiation. J Endocrinol 219, 279289.
  • 47
    Garces, M. F., Sanchez, E., Acosta, B. J., Angel, E., Ruiz, A. I., et al. (2012) Expression and regulation of chemerin during rat pregnancy. Placenta 33, 373378.
  • 48
    Ritterath, C., Rad, N. T., Siegmund, T., Heinze, T., Siebert, G., et al. (2010) Adiponectin during pregnancy: correlation with fat metabolism, but not with carbohydrate metabolism. Arch. Gynecol. Obstet. 281, 9196.
  • 49
    Ha, Y. J., Kang, E. J., Song, J. S., Park, Y. B., Lee, S. K., et al. Plasma chemerin levels in rheumatoid arthritis are correlated with disease activity rather than obesity. Joint Bone Spine, in press.
  • 50
    Herenius, M. M., Oliveira, A. S., Wijbrandts, C. A., Gerlag, D. M., Tak, P. P., et al. (2013) Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation. PLoS One 8, e57802.
  • 51
    Cash, J. L., Hart, R., Russ, A., Dixon, J. P. C., Colledge, W. H., et al. (2008) Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J. Exp. Med. 205, 767775.
  • 52
    Bondue, B., De Henau, O., Luangsay, S., Devosse, T., de Nadai, P., et al. (2012) The chemerin/ChemR23 system does not affect the pro-inflammatory response of mouse and human macrophages ex vivo. PLoS One 7, e40043.
  • 53
    Lora, V., Bonaguri, C., Gisondi, P., Sandei, F., Battistelli, L., et al. (2013) Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab. Immunol. Res. 56, 382389.
  • 54
    Banas, M., Zabieglo, K., Kasetty, G., Kapinska-Mrowiecka, M., Borowczyk, J., et al. (2013) Chemerin is an antimicrobial agent in human epidermis. PLoS One 8, e58709.
  • 55
    Pachynski, R. K., Zabel, B. A., Kohrt, H. E., Tejeda, N. M., Monnier, J., et al. (2012) The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses. J. Exp. Med. 209, 14271435.